Evidence map›Paper›PMID 35325270›Full record

ArticleClinical research in cardiology : official journal of the German Cardiac Society2022

Risk-related short-term clinical outcomes after transcatheter aortic valve implantation and their impact on early mortality: an analysis of claims-based data from Germany.

Niklas Schofer, Elke Jeschke, Janine Kröger, Henning Baberg, Volkmar Falk, Jan F Gummert, Christian W Hamm, Martin Möckel, Alina Goßling, Jürgen Malzahn and 2 more

Abstract read
In one paragraph

Article in Clinical research in cardiology : official journal of the German Cardiac Society, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Niklas Schofer *Department of General and Interventional Cardiology, University Heart Center Hamburg, Martinistrasse 52, 20246, Hamburg, Germany. n.schofer@uke.de.ORCID http://orcid.org/0000-0001-5190-813X
Elke Jeschke *Research Institute of the Local Health Care Funds, Berlin, Germany.
Janine KrögerResearch Institute of the Local Health Care Funds, Berlin, Germany.
Henning BabergDepartment of Cardiology and Nephrology, Helios Klinikum, Berlin-Buch, Berlin, Germany.
Volkmar FalkDepartment of Cardiothoracic and Vascular Surgery, Deutsches Herzzentrum Berlin, Berlin, Germany.
Jan F GummertClinic for Thoracic and Cardiovascular Surgery, Heart and Diabetes Center NRW, Ruhr University Bochum, Bad Oeynhausen, Germany.
Christian W HammMedical Clinic I, University of Giessen and Campus Kerckhoff, Giessen/Bad Nauheim, Germany.
Martin MöckelDivision of Emergency Medicine and Chest Pain Units, Department of Cardiology, Campus Virchow-Klinikum and Mitte, Charité-Universitätsmedizin Berlin, Berlin, Germany.
Alina GoßlingDepartment of General and Interventional Cardiology, University Heart Center Hamburg, Martinistrasse 52, 20246, Hamburg, Germany.
Jürgen MalzahnFederal Association of the Local Health Care Funds (AOK), Baden-Württemberg, Germany.
Christian GünsterResearch Institute of the Local Health Care Funds, Berlin, Germany.
Stefan BlankenbergDepartment of General and Interventional Cardiology, University Heart Center Hamburg, Martinistrasse 52, 20246, Hamburg, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesWe aimed to define and assess risk-specific adverse outcomes after transcatheter aortic valve implantation (TAVI) in an all-comers patient population based on German administrative claims data.

methodsAdministrative claims data of patients undergoing transvascular TAVI between 2017 and 2019 derived from the largest provider of statutory health-care insurance in Germany were used. Patients' risk profile was assessed using the established Hospital Frailty Risk (HFR) score and 30-day adverse events were evaluated. Multivariable logistic regression models were applied to investigate the relation of patients' risk factors to clinical outcomes and, subsequently, of clinical outcomes to mortality.

resultsA total of 21,430 patients were included in the analysis. Of those, 51% were categorized as low-, 37% as intermediate-, and 12% as high-risk TAVI patients according to HFR score. Whereas low-risk TAVI patients showed low rates of periprocedural adverse events, TAVI patients at intermediate or high risk suffered from worse outcomes. An increase in HFR score was associated with an increased risk for all adverse outcome measures. The strongest association of patients' risk profile and outcome was present for cerebrovascular events and acute renal failure after TAVI. Independent of patients' risk, the latter showed the strongest relation with early mortality after TAVI.

conclusionsDifferentiated outcomes after TAVI can be assessed using claims-based data and are highly dependent on patients' risk profile. The present study might be of use to define risk-adjusted outcome margins for TAVI patients in Germany on the basis of health-insurance data.

Indexed as

Aortic Valve StenosisFrailtyHeart Valve Prosthesis ImplantationTranscatheter Aortic Valve ReplacementAortic ValveGermanyHumansRisk FactorsTreatment OutcomeAortic stenosisClaims-based dataRisk-related outcomesTAVI

Identifiers

PMID35325270
PMCPMC9334430

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.